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The active ingredient of the tetanus vaccine, known as tetanus toxoid (TTD, 150 kDa), is prepared by
inactivation of the tetanus toxin with formaldehyde. This chemical treatment determines the efficiency and
innocuity of the vaccine. The detoxification chemistry has been qualitatively studied regarding the nature and
positioning of some formaldehyde-induced modifications. However, neither the stoichiometry of the chemical
modifications or intra- and inter-chain cross-linking have been yet characterized, despite being of great interest
for the definitive elucidation of the detoxification mechanism as well as for future manufacturing follow-up. The
aim of the present study is to assess the impact of formaldehyde on TTD by identifying, mapping, and
quantifying as exhaustively as possible, all formaldehyde-induced modifications over the entire threedimensional (3D) structure of the protein.
The analytical strategy was very effective and allowed to identify ≥100 formaldehyde modifications. These
modifications were localized on 70 amino acid residues of lysines, tyrosines, asparagines, tryptophanes,
glutamines, arginines and histidines. Several methylene-type cross-links were unambiguously characterized for
the first time in the subunits and across the light and heavy TTD. After identifying the nature and location of all
formaldehyde-induced modifications on the primary sequence of TTD, we mapped them over the entire 3D
structure of the protein.

A label-free quantification approach based on the reconstructed peak area from the first MS dimension of both
the non- and chemically-modified forms of each peptide was performed to estimate the rate of formaldehydeinduced modifications in TTD.
Detoxification of the toxin at the molecular level could be explained by some (if not all) formaldehyde-induced
modifications characterized in this study. The inter-chain cross-links could explain why the light and heavy
chains linked with a disulfide bridge do not dissociate after reducing treatment, thus supporting TTD safety.
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